Closed · HT9425-23-PRARP-TRA · CFDA 12.420 · Discretionary
DOD, Peer Reviewed Alzheimer’s, Transforming Research Award
Federal grant opportunity posted by Defense Health Agency Contracting Activity - DHACA, cataloged on Grants.gov.
- Varies
- Award range
- Closed
- Status
- July 25, 2023
- Close date
- 4
- Expected awards
The verdict
DOD, Peer Reviewed Alzheimer’s, Transforming Research Award is a closed discretionary listing from Defense Health Agency Contracting Activity - DHACA that offered Varies by applicant across 4 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 1,795 other opportunities from Defense Health Agency Contracting Activity - DHACA.
- Varies
- award range
- Closed
- application status
- 4
- expected awards
- 12.420
- CFDA program
Archived opportunity record
DOD, Peer Reviewed Alzheimer’s, Transforming… is closed (last close July 25, 2023). Check the agency catalog for replacement NOFOs. Defense Health Agency Contracting Activity - DHACA still indexes 1,795 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed July 25, 2023
Est. Total Funding
$4,000,000
Expected Awards
4
Instrument
Grant
Description
The FY23 PRARP TRA is intended to support studies that will make transformative and advanced contributions to reduce risk of or prevent the development of AD/ADRD. Risk reduction considering TBI and/or military service is of particular interest to the program. The work should significantly accelerate efforts in AD/ADRD research and demonstrate significant positive impact toward improving patient care and/or quality of life.Key elements of this award mechanism include:• Research should be robust: The FY23 PRARP TRA mechanism is geared toward supporting robust, well designed research projects that provide significant, near-term impact on the AD/ADRD field, persons living with dementia, and their families, care-partners/caregivers, and communities. To ensure near-term applicability, inclusion of collaborative community partner approaches is strongly encouraged for all projects and is required for all projects involving clinical research.• Non-incremental advancement: Research projects should leverage existing knowledge to accelerate ideas, strengthen evidence, and move the field forward toward nearer-term impact. Projects proposing incremental advances that do not significantly propel the field are not appropriate for this mechanism.• Feedback to the community: Results and outcomes of the research supported by this mechanism must be relayed back to the community to allow for continued knowledge building.Inclusion of preliminary data is required. Use of animal models must be fully justified for relevance to human health. Clinical research applications are required to include a community collaboration research element.
Catch-all / unrestricted eligibility mark · HT9425-23-PRARP-TRA
Grants.gov marks DOD, Peer Reviewed Alzheimer’s, Transforming… with a catch-all / unrestricted eligibility code (Unrestricted / see official listing). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity code maps to Science and Technology / R&D (ST). This eligibility-code string dominates the Defense Health Agency Contracting Activity - DHACA book (1,791 peers, 100% of 1,796).
- Code 99
- Unrestricted / see official listing
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org
More from Defense Health Agency Contracting Activity - DHACA
DoW Neurofibromatosis Synergistic Idea Award
DoW Neurofibromatosis Investigator-Initiated Research Award
DoW Neurofibromatosis Research Academy – Scholar Award
DoW Neurofibromatosis Exploration-Hypothesis Development Award
DOW Combat Readiness – Medical Research Program Translational Research Award
What to do next
DOD, Peer Reviewed Alzheimer’s, Transforming… is closed; use the parent program and agency catalog for the next funding cycle.
- Browse open federal opportunities in the same category when this listing is closed. Open opportunities
- Look up CFDA 12.420 across all indexed listings before you commit to this opportunity alone. Eligibility finder
- Compare award ranges across federal categories before you pick a single CFDA. All categories
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |